Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schwartz JJ, Myskowski PL: Molluscum contagiosum in patients with human immunodeficiency virus infection: A review of twenty-seven patients. J Am Acad Dermatol 1992, 27:583–588.
Robinson MR, Udell IJ, Garber PF, et al.: Molluscum contagiosum of the eyelids in patients with acquired immune deficiency syndrome. Ophthalmology 1992, 99:1745–1747.
Sandor EV, Millman A, Croxson TS, Mildvan D: Herpes zoster ophthalmicus in patients at risk for the acquired immune deficiency syndrome (AIDS). Am J Ophthalmol 1986, 101:153–155.
Sellitti TP, Huang AJ, Schiffman J, Davis JL: Association of herpes zoster ophthalmicus with acquired immunodeficiency syndrome and acute retinal necrosis. Am J Ophthalmol 1993, 116:297–301.
Litoff D, Catalano RA: Herpes zoster optic neuritis in human immunodeficiency virus infection. Arch Ophthalmol 1990, 108:782–783.
McLeish W, Pflugfelder SC, Crouse C, et al.: Interferon treatment of herpetic keratitis in a patient with acquired immunodeficiency syndrome. Am J Ophthalmol 1990, 109:93–95.
Young TL, Robin JB, Holland GN, et al.: Herpes simplex keratitis in patients with acquired immune deficiency syndrome. Ophthalmology 1989, 96:1476–1479.
Schwartz DA, Visvesvara GS, Diesenhouse MC, et al.: Pathologic features and immunofluorescent antibody demonstration of ocular microsporidiosis (Encephalitozoon hellem) in seven patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993, 115:285–292.
Buus DR, Pflugfelder SC, Schacter J, et al.: Lymphogranuloma venereum conjunctivitis with a marginal corneal perforation. Ophthalmology 1988, 95:799–802.
Nanda M, Pflugfelder SC, Holland S: Fulminant pseudomonal keratitis and scleritis in human immunodeficiency virus-infected patients. Arch Ophthalmol 1991, 109:503–505.
Spaide RF, Vitale AT, Toth IR, Oliver JM: Frosted branch angiitis associated with cytomegalovirus retinitis. Am J Ophthalmol 1992, 113:522–528.
Jabs DA, Enger C, Bartlett JG: Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Opthalmol 1989, 107:75–80.
The Ocular Complications of AIDS Study Group: Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992, 326:213–220.
Jabs DA, Enger C, Haller J, de Bustros S: Retinal detachments in patients with cytomegalovirus retinitis. Arch Ophthalmol 1991, 109:794–799.
Freeman WR, Friedberg DN, Berry C, et al.: Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol 1993, 116:713–720.
Freeman WR, Wiley CA, Gross JG, et al.: Endoretinal biopsy in immuno-suppressed and healthy patients with retinitis: Indications, utility, and techniques. Ophthalmology 1989, 96:1559–1565.
Gross JG, Sadun AA, Wiley CA, Freeman WR: Severe visual loss related to isolated peripapillary retinal and optic nerve head cytomegalovirus infection. Am J Ophthalmol 1989, 108:691–698.
Martin DF, Dunn JP, Davis JL, et al.: Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel. Am J Ophthalmol 1999, 329–339.
Vrabec TR, Baldassano VF, Whitcup SM : Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology 1998, 105:1259–1264.
Davis JL, Tabandeh H, Feuer WJ, et al.: Effect of potent antiretroviral therapy on recurrent cytomegalovirus retinitis treated with the ganciclovir implant. Am J Ophthalmol 1999, 127:283–287.
Cassoux N, Lumbroso L, Bodaghi B, et al.: Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly activated antiretroviral therapy. Br J Ophthalmol 1999, 83:47–49.
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Am J Ophthalmol 1997, 124:141 – 157.
Martin DF, Parks DJ, Mellow SD, et al.: Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 1994, 112:1531–1539.
Arevalo JF, Gonzalez C, Capparelli EV, et al.: Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis. J Infect Dis 1995, 172:951–956.
Duker JS, Nielsen JC, Eagle RCJ, et al.: Rapidly progressive acute retinal necrosis secondary to herpes simplex virus, type 1. Ophthalmology 1990, 97:1638.
Margolis TP, Lowder CY, Holland GN, et al.: Varicella-zoster virus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1991, 112:119–131.
Heinemann MH, Bloom AF, Horowitz J: Candida albicans endophthalmitis in a patient with AIDS: Case report. Arch Ophthalmol 1987, 105:1172–1173.
Brod RD, Flynn HJ, Clarkson JG, et al.: Endogenous Candida endophthalmitis: Management without intravenous amphotericin B. Ophthalmology 1990, 97:666–672.
Kupfer C, McCrane E: A possible cause of decreased vision in cryptococcal meningitis. Invest Ophthalmol 1974, 13:801–804.
Cochereau MI, LeHoang P, Lautier FM, et al.: Ocular toxoplasmosis in human immunodeficiency virus-infected patients. Am J Ophthalmol 1992, 114:130–135.
Iannucci AA, Hart LL: Clindamycin in the treatment of toxoplasmosis in AIDS. Ann Pharmacother 1992, 26:645–647.
Kovacs JA: Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program. Lancet 1992, 340:637–638.
Elkins BS, Holland GN, Opremcak EM, et al.: Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology 1994, 101:499–507.
Rao NA, Zimmerman PL, Boyer D, et al.: A clinical, histopathologic, and electron microscopic study of Pneumocystis carinii choroiditis. Am J Ophthalmol 1989, 107:218–228.
Dugel PU, Rao NA, Forster DJ, et al.: Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. Am J Ophthalmol 1990, 110:113–117.
Blodi BA, Johnson MW, McLeish WM, Gass JD: Presumed choroidal tuberculosis in a human immunodeficiency virus infected host. Am J Ophthalmol 1989, 108:605–607.
Pepose JS, Holland GN, Nestor MS, et al.: Acquired immune deficiency syndrome: Pathogenic mechanisms of ocular disease. Ophthalmology 1985, 92:472–484.
Davis JL, Nussenblatt RB, Bachman DM, et al.: Endogenous bacterial retinitis in AIDS. Am J Ophthalmol 1989, 107:613–623.
McLeish WM, Pulido JS, Holland S, et al.: The occular manifestations of syphilis in the human immunodeficiency virus type 1 -infected host. Ophthalmology 1990, 97:196–203.
Young SH, Morlet N, Heery S, et al.: High-dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitis. Med J Aust 1992, 157:370–373.
Alvarez R, Adan A, Martinez JA, et al.: Haematogenous Serratia marcescens endophthalmitis in an HIV-infected intravenous drug addict. Infection 1990, 18:29–30.
Shafran SD, Deschenes J, Miller M, et al.: Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol: MAC Study Group of the Canadian HIV Trials Network [letter]. N Engl J Med 1994, 330:438–439.
Selected Bibliography
Engstrom RE, Holland GN, Margolis TP, et al.: The progressive outer retinal necrosis syndrome: A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology 1994, 101:1488–1502.
Freeman WR, Friedberg DN, Berry C, et al.: Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol 1993, 116:713–720.
Martin DF, Parks DJ, Mellow SD, et al.: Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 1994, 112:1531–1539.
Studies of the Ocular Complications of AIDS Research Group with the AIDS Clinical Trials Group: Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. ARch Ophthalmol 1996, 114:23–33.
Studies of the Ocular Complications of AIDS Research Group with the AIDS Clinical Trials Group: Foscarnet-ganciclovir cytomegalovirus retinitis trial 4: Visual outcomes. Ophthalmology 1994, 101:1250–1261.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Davis, J.L., Palestine, A.G. (2001). Ophthalmic Manifestations. In: Mandell, G.L., Mildvan, D. (eds) Atlas of AIDS. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4549-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4549-8_6
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-4551-1
Online ISBN: 978-1-4757-4549-8
eBook Packages: Springer Book Archive